204 related articles for article (PubMed ID: 15072469)
1. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.
Kayaselçuk F; Zorludemir S; Bal N; Erdogan B; Erdogan S; Erman T
J Neurooncol; 2004; 67(1-2):209-14. PubMed ID: 15072469
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
3. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
4. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
5. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
[TBL] [Abstract][Full Text] [Related]
6. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
7. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
Barresi V; Alafaci C; Salpietro F; Tuccari G
Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
[TBL] [Abstract][Full Text] [Related]
8. Characterization of morphologically benign biologically aggressive meningiomas.
Rao S; Sadiya N; Doraiswami S; Prathiba D
Neurol India; 2009; 57(6):744-8. PubMed ID: 20139503
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of MMP-9, PR, Ki-67 and Survivin in multiple meningiomas].
Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3218-20. PubMed ID: 23328471
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
11. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
[TBL] [Abstract][Full Text] [Related]
12. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
Lee SH; Lee YS; Hong YG; Kang CS
APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
[TBL] [Abstract][Full Text] [Related]
13. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
15. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
16. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
Korshunov AG; Shishkina LV; Golanov AV
Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
[TBL] [Abstract][Full Text] [Related]
17. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
18. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
[TBL] [Abstract][Full Text] [Related]
19. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
[TBL] [Abstract][Full Text] [Related]
20. PTTG-1 (Securin) immunoexpression in meningiomas correlates with tumor grade and proliferation rate: potential use as a diagnostic marker of malignancy.
Iliadis A; Virvili MA; Flaris NA; Pervana S; Pazarli E; Tripsianis G; Grigoriou ME; Efstratiou I; Kanakis DN
APMIS; 2018 Apr; 126(4):295-302. PubMed ID: 29575197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]